PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31010051-3 2019 Upon stimulating IL-32theta-expressing and non-expressing cells with phorbol 12-myristate 13-acetate (PMA), the previous microarray analysis showed that IL-13Ralpha2 and IL-13 mRNA expression were significantly decreased by IL-32theta. Tetradecanoylphorbol Acetate 69-100 interleukin 32 Homo sapiens 17-22 31010051-3 2019 Upon stimulating IL-32theta-expressing and non-expressing cells with phorbol 12-myristate 13-acetate (PMA), the previous microarray analysis showed that IL-13Ralpha2 and IL-13 mRNA expression were significantly decreased by IL-32theta. Tetradecanoylphorbol Acetate 102-105 interleukin 32 Homo sapiens 17-22 23814099-4 2013 We observed that the phosphorylation of C/EBPalpha Ser-21 was inhibited by a PKCdelta-specific inhibitor, rottlerin, or IL-32beta knockdown by siRNA and that IL-32beta shifted to the membrane from the cytosol upon phorbol 12-myristate 13-acetate treatment. Tetradecanoylphorbol Acetate 214-245 interleukin 32 Homo sapiens 158-167 25178676-5 2014 We demonstrated that IL-32alpha interacts with protein kinase C (PKC)delta and PKCe in a phorbol 12-myristate 13-acetate (PMA) dependent way, and that PKCe regulates the interaction of IL-32alpha with PLZF. Tetradecanoylphorbol Acetate 89-120 interleukin 32 Homo sapiens 21-31 25178676-5 2014 We demonstrated that IL-32alpha interacts with protein kinase C (PKC)delta and PKCe in a phorbol 12-myristate 13-acetate (PMA) dependent way, and that PKCe regulates the interaction of IL-32alpha with PLZF. Tetradecanoylphorbol Acetate 122-125 interleukin 32 Homo sapiens 21-31 25178676-5 2014 We demonstrated that IL-32alpha interacts with protein kinase C (PKC)delta and PKCe in a phorbol 12-myristate 13-acetate (PMA) dependent way, and that PKCe regulates the interaction of IL-32alpha with PLZF. Tetradecanoylphorbol Acetate 122-125 interleukin 32 Homo sapiens 185-195 25245533-3 2014 In this study, we showed that PMA induces an interaction between IL-32alpha, PKCepsilon, and BCL6, forming a trimer. Tetradecanoylphorbol Acetate 30-33 interleukin 32 Homo sapiens 65-75 25245533-7 2014 Further, the pan-PKC inhibitor and PKCepsilon inhibitor disrupted PMA-induced interaction between IL-32alpha and BCL6. Tetradecanoylphorbol Acetate 66-69 interleukin 32 Homo sapiens 98-108 24996056-2 2014 Here, we confirmed that IL-32theta, a new isoform of IL-32, decreased the phorbol 12-myristate 13-acetate (PMA)-induced IL-1beta expression in THP-1 human myelomonocyte. Tetradecanoylphorbol Acetate 74-105 interleukin 32 Homo sapiens 24-29 24996056-2 2014 Here, we confirmed that IL-32theta, a new isoform of IL-32, decreased the phorbol 12-myristate 13-acetate (PMA)-induced IL-1beta expression in THP-1 human myelomonocyte. Tetradecanoylphorbol Acetate 107-110 interleukin 32 Homo sapiens 24-29 26516703-7 2015 Using an IL-32theta stable expression system in leukemia cell lines, we found that IL-32theta attenuated phorbol 12-myristate 13-acetate (PMA)-induced TNF-alpha production. Tetradecanoylphorbol Acetate 105-136 interleukin 32 Homo sapiens 9-14 26516703-7 2015 Using an IL-32theta stable expression system in leukemia cell lines, we found that IL-32theta attenuated phorbol 12-myristate 13-acetate (PMA)-induced TNF-alpha production. Tetradecanoylphorbol Acetate 105-136 interleukin 32 Homo sapiens 83-88 26516703-7 2015 Using an IL-32theta stable expression system in leukemia cell lines, we found that IL-32theta attenuated phorbol 12-myristate 13-acetate (PMA)-induced TNF-alpha production. Tetradecanoylphorbol Acetate 138-141 interleukin 32 Homo sapiens 9-14 26516703-7 2015 Using an IL-32theta stable expression system in leukemia cell lines, we found that IL-32theta attenuated phorbol 12-myristate 13-acetate (PMA)-induced TNF-alpha production. Tetradecanoylphorbol Acetate 138-141 interleukin 32 Homo sapiens 83-88 25726525-5 2015 Using previously established cell lines that stably express IL-32theta and IL-32beta and cell lines transiently expressing IL-32theta, we observed that expression of IL-32theta inhibited phorbol 12-myristate 13-acetate (PMA)-induced monocytic differentiation in both THP-1 and HL-60 cells. Tetradecanoylphorbol Acetate 187-218 interleukin 32 Homo sapiens 75-84 25726525-5 2015 Using previously established cell lines that stably express IL-32theta and IL-32beta and cell lines transiently expressing IL-32theta, we observed that expression of IL-32theta inhibited phorbol 12-myristate 13-acetate (PMA)-induced monocytic differentiation in both THP-1 and HL-60 cells. Tetradecanoylphorbol Acetate 187-218 interleukin 32 Homo sapiens 60-65 22927445-9 2012 PMA-induced enhancement of STAT3 phosphorylation was observed only in IL-32alpha-expressing cells, and this enhancement was inhibited by Ro-31-8220, but not by Go6976. Tetradecanoylphorbol Acetate 0-3 interleukin 32 Homo sapiens 70-80 19740314-4 2009 This report confirms, using IL-32 small interfering RNA, that IL-32beta induces an anti-inflammatory cytokine IL-10 in K562-IL-32beta cells and U937 promonocytic cells, which express endogenous IL-32beta upon phorbol 12-myristate 13-acetate (PMA) treatment, and monocyte-derived dendritic cells (DC) upon lipopolysaccharide (LPS) treatment. Tetradecanoylphorbol Acetate 209-240 interleukin 32 Homo sapiens 62-71 22927445-4 2012 We show that phorbol 12-myristate 13-acetate (PMA)-induced increase in IL-6 production by IL-32alpha-expressing cells was higher than that by empty vector-expressing cells and that this increase occurred in a time- and dose-dependent manner. Tetradecanoylphorbol Acetate 13-44 interleukin 32 Homo sapiens 90-100 22927445-4 2012 We show that phorbol 12-myristate 13-acetate (PMA)-induced increase in IL-6 production by IL-32alpha-expressing cells was higher than that by empty vector-expressing cells and that this increase occurred in a time- and dose-dependent manner. Tetradecanoylphorbol Acetate 46-49 interleukin 32 Homo sapiens 90-100 19880327-5 2010 Indeed, lipopolysaccharide (LPS)- or phorbol myristate acetate (PMA)-induced proinflammatory cytokine production was significantly inhibited in shRNA/IL-32 stable clones as compared to control clones. Tetradecanoylphorbol Acetate 37-62 interleukin 32 Homo sapiens 150-155 19880327-5 2010 Indeed, lipopolysaccharide (LPS)- or phorbol myristate acetate (PMA)-induced proinflammatory cytokine production was significantly inhibited in shRNA/IL-32 stable clones as compared to control clones. Tetradecanoylphorbol Acetate 64-67 interleukin 32 Homo sapiens 150-155 19740314-4 2009 This report confirms, using IL-32 small interfering RNA, that IL-32beta induces an anti-inflammatory cytokine IL-10 in K562-IL-32beta cells and U937 promonocytic cells, which express endogenous IL-32beta upon phorbol 12-myristate 13-acetate (PMA) treatment, and monocyte-derived dendritic cells (DC) upon lipopolysaccharide (LPS) treatment. Tetradecanoylphorbol Acetate 242-245 interleukin 32 Homo sapiens 62-71